Serological Assays for the Detection and Characterization of Influenza Viruses

Closed — responses were due 7 May 2025 · Unrestricted (full and open) · Centers for Disease Control and Prevention (CDC), HHS · Atlanta, GA · NAICS 325413 · Solicitation 75D30125R73235

Following NAICS 325413? Get new solicitations in it by email as they post — no account needed.

Email me new ones

What happened next

This solicitation has closed — responses were due 07 May 2025.

No award notice on SAM.gov yet. Not every award is posted there, so this does not mean it went unawarded.

Email me when the award is announced. One email, when SAM.gov posts the award notice. Not every award is posted there; if none appears within six months we'll tell you and stop. No account needed.

Looking for similar live work? Open NAICS 325413 solicitations → in the FedSift app, no account needed
Contracts in this category ending in the next 18 months → NAICS 325413 at HHS · in the recompete radar · free account

Solicitation details

Solicitation number	75D30125R73235
Notice ID	742fa6578c864e11a0da51d8dbf3d98e
Agency	Department of Health and Human Services (HHS)
Sub-agency	Centers for Disease Control and Prevention (CDC)
Contracting office	CDC OFFICE OF ACQUISITION SERVICES
NAICS code	325413 — In-Vitro Diagnostic Substance Manufacturing
Product / service code (PSC)	Q301
Set-aside	Unrestricted (full and open)
Notice type	Solicitation
Posted	19 February 2025
Response deadline	07 May 2025 (closed)
Place of performance	Atlanta, GA, USA

Get new NAICS 325413 solicitations by email

This one has closed. We'll email you when new NAICS 325413 (In-Vitro Diagnostic Substance Manufacturing) solicitations post — the first email lists what is open right now, then at most once a week, only when something new posts. No account needed; unsubscribe in a click.

Description

Amendment 1 is being issued to push back the due dates for Phase I and Phase II. A PDF copy of the amendment is attached as well as a Word version showing the track changes to the document. The objective of this contract is to support the Influenza Division through the testing of human sera via hemagglutination inhibition assay as well as develop a new serology platform that is comparable to hemagglutination inhibition assay. This is Phase I of a a two phased multi-step mandatory down select solicitation. Interest for Phase I is due to the contracting officer no later than 2:00 PM EST February 21, 2025. The steps in Phase I are as follows: Letter of Interest – offerors shall email POC information to Contracting Officer Proficiency panel will be sent by CDC to intersted offerors Vendor shall email results to CDC Contracting Officer CDC Contractng Officer will notify each offeror of their pass/fail status for Phase I and if they are then able to proceed to Phase II

Version history

SAM.gov has posted 7 notices under solicitation 75D30125R73235, oldest first.

16 January 2025 — Solicitation
19 February 2025 — Solicitation (this page)
18 March 2025 — Solicitation
26 March 2025 — Solicitation
15 April 2025 — Solicitation
11 December 2025 — Solicitation
11 December 2025 — Solicitation (latest)

Go deeper on this solicitation

FedSift reads the full solicitation package — every attachment — and pre-extracts the compliance matrix, evaluation factors, key risks, win themes and deal-breakers, each with a verbatim quote and the exact PDF page it came from. It scores the opportunity against your company profile, tells you whether to bid as prime or sub, and ranks teaming partners who could close your gaps.

Open the AI analysis in FedSift →

Free forever plan — no credit card. Browse solicitations without an account; sign in for AI analysis and matching.

Market context: HHS and NAICS 325413

About the buyer and the industry, not this specific solicitation. Source: USASpending.gov award data, updated nightly.

In fiscal year 2026, HHS obligated $12.6M across 112 contract actions under NAICS 325413.
60 contracts worth $47.2M in this category end within the next 18 months.

HHS contracts under NAICS 325413 →

Other open solicitations in NAICS 325413

6550--Blood Type IVD ReagentsVA · Due 16 November 2026
6550--Cepheid GeneXpert Testing SuppliesVA · Due 16 November 2026
Reagents and consumables for Roche immunostainersHHS · Due 18 November 2026
VA Boise, Idaho Medical Center Lab - New Blood Reagents RequirementVA · Due 18 November 2026
BPA - Consumable Supplies for Terumo Trima Accel Blood Collection systemsDoD · Due 20 November 2026
Sole Source BioFire - Gastrointestinal Panel IVD and Respiratory Panel 2.1 IVDDoD · Due 23 November 2026
6550--HEMOCHRON SIGNATURE ELITE REAGENTS AND SUPPLIESVA · Due 27 November 2026
6550 Reagents Consumables Microbiology Testing Boise VAMCVA · Due 27 November 2026

All NAICS 325413 solicitations →

More from Department of Health and Human Services

Service AgreementHHS · Due 15 November 2026
Service AgreementHHS · Due 15 November 2026
ORSC Certification and Testing ContractHHS · Due 15 November 2026
Liquid Nitrogen Gas (LN2) service for Clinical Biorepository FreezersHHS · Due 16 November 2026
Takeda Group's Gammagard (Notice of Intent to Sole Source)HHS · Due 16 November 2026
Notice of Intent to Sole Source - NNMC Laboratory Proficiency Testing ServicesHHS · Due 16 November 2026
NNMC Water testing, analysis, and filtration services for medical device processingHHS · Due 16 November 2026
License to Access the American Hospital Association Inc.’s (AHA) Proprietary Databases, Training, and Technical SupportHHS · Due 16 November 2026

All HHS solicitations →

Source: this notice on SAM.gov. FedSift republishes public federal procurement data and is not affiliated with the U.S. Government. Always confirm dates and requirements against SAM.gov before responding.